(Q52172674)

26 April 2018

title

Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone. (English)

1 reference

26 April 2018

1 reference

J R Walker

1

1 reference

26 April 2018

M King

2

1 reference

26 April 2018

E Izzo

3

1 reference

26 April 2018

G F Koob

4

1 reference

26 April 2018

G W Pasternak

5

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

26 April 2018

European Journal of Pharmacology

published in

1 reference

26 April 2018

volume

383

1 reference

26 April 2018

issue

2

1 reference

26 April 2018

page(s)

115-119

1 reference

26 April 2018

Morphine-6-glucuronide contributes to rewarding effects of opiates.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Cocaine- but not food-seeking behavior is reinstated by stress after extinction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Opiate receptors in mice: Genetic differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

3-Methoxynaltrexone, a selective heroin/morphine-6beta-glucuronide antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Dosage choices of rats for morphine, for heroin, and between morphine and heroin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Pharmacological mechanisms of opioid analgesics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Strain differences in opiate receptors in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Synergistic brainstem interactions for morphine analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Factors affecting voluntary morphine intake in self-maintained addicted rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900633-0

10.1016/S0014-2999(99)00633-0

7 January 2021

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

10585524

1 reference

26 April 2018